Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Feb 18;14(2):e22359.
doi: 10.7759/cureus.22359. eCollection 2022 Feb.

Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in a Patient Taking Lamotrigine: A Case Report Based Literature Review

Affiliations
Case Reports

Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in a Patient Taking Lamotrigine: A Case Report Based Literature Review

Zahid Khan et al. Cureus. .

Abstract

A 29-year-old patient presented to the hospital with worsening generalized rash for the last two days from a mental health facility. The patient was commenced on lamotrigine two weeks earlier, and he developed fever and generalized macular rash on his body. His blood tests showed deranged liver function tests (LFTs) and clotting with raised eosinophil count, and he was treated for lamotrigine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. The patient was commenced on prednisolone 50 mg once daily with a proton pump inhibitor cover, and lamotrigine was suspended on advice from Dermatology. The patient showed improvement after 3-4 days of treatment. His skin biopsy showed prominent suppurative granulomatous folliculitis, mild perivascular chronic inflammation, and red blood cell extravasation, including the rare eosinophil. He was weaned off from prednisolone by 5 mg weekly and had complete resolution of symptoms.

Keywords: allergy and anaphylaxis; allergy test; drug-induced hepatitis; drug-induced urticarial rash; generalized rash; high fever; international normalized; international normalized ratio; systemic steroids.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. An uncommon presentation of DRESS syndrome secondary to leflunomide use: a case report. Rao S, Sunkara A, Srivastava N, Sampat P, Ramos C, Albert E. J Investig Med High Impact Case Rep. 2021;9:2324709621997282. - PMC - PubMed
    1. Interleukin-10 is increased in successful drug desensitization regardless of the hypersensitivity reaction type. Gelincik A, Demir S, Şen F, et al. Asia Pac Allergy. 2019;9:0. - PMC - PubMed
    1. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Peyrière H, Dereure O, Breton H, Demoly P, Cociglio M, Blayac JP, Hillaire-Buys D. Br J Dermatol. 2006;155:422–428. - PubMed
    1. General considerations on rapid desensitization for drug hypersensitivity - a consensus statement. Cernadas JR, Brockow K, Romano A, et al. Allergy. 2010;65:1357–1366. - PubMed
    1. Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system. Cho YT, Yang CW, Chu CY. Int J Mol Sci. 2017;18:1243. - PMC - PubMed

Publication types

LinkOut - more resources